Search the collection

Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 1
ArticlesPeer ReviewedFull Text
Once-daily atazanavir/ritonavir versus twice-daily lopinavir/ritonavir, each in combination with tenofovir and emtricitabine, for management of antiretroviral-naive HIV-1-infected patients: 48 week ef...
Author / Creator:Molina, Jean-Michel, Prof ; Andrade-Villanueva, Jaime, MD ; Echevarria, Juan, MD ; Chetchotisakd, Ploenchan, Prof ; Corral, Jorge, MD ; David, Neal, FCFP [SA] ; Moyle, Graeme, MD ; Mancini, Marco, BS ; Percival, Lisa, MS ; Yang, Rong, PhD ; Thiry, Alexandra, PhD ; McGrath, Donnie, MD
Publisher:England: Elsevier Ltd
Journal title:The Lancet (British edition), 2008-08, Vol.372 (9639), p.646-655
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 2
ArticlesPeer ReviewedFull Text
Identification of I50L as the Signature Atazanavir (ATV)-Resistance Mutation in Treatment-Naive HIV-1-Infected Patients Receiving ATV-Containing Regimens
Author / Creator:Colonno, Richard ; Rose, Ronald ; McLaren, Colin ; Thiry, Alexandra ; Parkin, Neil ; Friborg, Jacques
Publisher:Chicago, IL: The University of Chicago Press
Journal title:The Journal of infectious diseases, 2004-05, Vol.189 (10), p.1802-1810
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 3
ArticlesPeer ReviewedFull Text
Body Fat and Other Metabolic Effects of Atazanavir and Efavirenz, Each Administered in Combination with Zidovudine plus Lamivudine, in Antiretroviral- Naive HIV-Infected Patients
Author / Creator:Jemsek, Joseph G ; Arathoon, Eduardo ; Arlotti, Massimo ; Perez, Carlos ; Sosa, Nestor ; Pokrovskiy, Vadim ; Thiry, Alexandra ; Soccodato, Michael ; Noor, Mustafa A. ; Giordano, Michael
Publisher:United States: The University of Chicago Press
Journal title:Clinical infectious diseases, 2006-01, Vol.42 (2), p.273-280
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 4
ArticlesPeer ReviewedFull Text
Discovery of the Novel Entecavir‐Resistant Hepatitis B Virus Reverse Transcriptase A181C Substitution From an Integrated Genotypic Analysis
Author / Creator:Rose, Ronald E. ; Hernandez, Dennis ; Falk, Paul J. ; Ericson, Karen ; Zhou, Nannan ; Thiry, Alexandra ; McPhee, Fiona
Publisher:United States: Wolters Kluwer Health Medical Research, Lippincott Williams & Wilkins
Journal title:Hepatology communications, 2018-09, Vol.2 (9), p.1123-1135
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 5
ArticlesPeer ReviewedFull Text
Safety of Rimegepant in Patients Using Preventive Migraine Medications: A Subgroup Analysis of a Long-Term, Open-Label Study Conducted in the United States
Author / Creator:Berman, Gary ; Thiry, Alexandra ; Croop, Robert
Publisher:New Zealand: Dove Medical Press Limited
Journal title:Journal of pain research, 2024-05, Vol.17, p.1805-1814
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 6
ArticlesPeer ReviewedFull Text
Efficacy and Safety of Rimegepant 75 mg Oral Tablet, a CGRP Receptor Antagonist, for the Acute Treatment of Migraine: A Randomized, Double-Blind, Placebo-Controlled Trial
Author / Creator:Lipton, Richard ; Thiry, Alexandra ; Morris, Beth ; Croop, Robert
Publisher:New Zealand: Dove Medical Press Limited
Journal title:Journal of pain research, 2024-01, Vol.17, p.2431-2441
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 7
ArticlesPeer ReviewedFull Text
Efficacy and Safety of Rimegepant 75 Mg Oral Tablet, a CGRP Receptor Antagonist, for the Acute Treatment of Migraine: A Randomized, Double-Blind, Placebo-Controlled Trial [Corrigendum]
Author / Creator:Lipton, Richard ; Thiry, Alexandra ; Morris, Beth ; Croop, Robert
Publisher:Dove
Journal title:Journal of pain research, 2024-12, Vol.17, p.4085-4086
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 8
ReportsFull Text
Safety of Rimegepant in Patients Using Preventive Migraine Medications: A Subgroup Analysis of a Long-Term, Open-Label Study Conducted in the United States
Author / Creator:Berman, Gary ; Thiry, Alexandra ; Croop, Robert
Journal title:Journal of pain research, 2024, Vol.17, p.1805-1814
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 9
ArticlesPeer ReviewedFull Text
Once-daily atazanavir/ritonavir versus twice-daily lopinavir/ritonavir, each in combination with tenofovir and emtricitabine, for management of antiretroviral-naive HIV-1-infected patients : 48 week e...
Author / Creator:TORTI, Carlo ; MOLINA, Jean-Michel ; RANG YANG ; THIRY, Alexandra ; MCGRATH, Donnie ; ANDRADE-VILLANUEVA, Jaime ; ECHEVARRIA, Juan ; CHETCHOTISAKD, Ploenchan ; CORRAL, Jorge ; DAVID, Neal ; MOYLE, Graeme ; MANCINI, Marco ; PERCIVAL, Lisa
Publisher:London: Lancet
Journal title:The Lancet (British edition), 2008, Vol.372 (9639)
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 10
ArticlesPeer ReviewedFull Text
Body fat and other metabolic effects of atazanavir and efavirenz, each administered in combination with zidovudine plus lamivudine, in antiretroviral- naive HIV-infected patients. Commentary
Author / Creator:JEMSEK, Joseph G ; ARATHOON, Eduardo ; DUBE, Michael P ; ARLOTTI, Massimo ; PEREZ, Carlos ; SOSA, Nestor ; POKROVSKIY, Vadim ; THIRY, Alexandra ; SOCCODATO, Michael ; NOOR, Mustafa A ; GIORDANO, Michael
Publisher:Chicago, IL: University of Chicago Press
Journal title:Clinical infectious diseases, 2006, Vol.42 (2), p.273-282
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 11
ArticlesPeer ReviewedFull Text
Atazanavir—A Once-daily HIV Protease Inhibitor That Does Not Cause Dyslipidemia in Newly Treated Patients: Results from Two Randomized Clinical Trials
Author / Creator:Cahn, Pedro E ; Gatell, José M ; Squires, Kathleen ; Percival, Lisa D ; Piliero Peter J ; Sanne, Ian A ; Shelton, Sarah ; Lazzarin Adriano ; Odeshoo Linda ; Kelleher, Thomas D ; Thiry, Alexandra ; Giordano, Michael D ; Schnittman, Stephen M
Publisher:Thousand Oaks: SAGE PUBLICATIONS, INC
Journal title:Journal of the International Association of Providers of AIDS Care, 2004-07, Vol.3 (3), p.92-98
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 12
ArticlesPeer ReviewedFull Text
Missing Data Methods in Hiv Clinical Trials: Regulatory Guidance and Alternative Approaches
Author / Creator:Kelleher, Thomas ; Thiry, Alexandra ; Wilber, Richard ; Cross, Anne
Publisher:Los Angeles, CA: SAGE Publications
Journal title:Therapeutic innovation & regulatory science, 2001-10, Vol.35 (4), p.1363-1371
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.

Export record to excel

Export this record

Export record to excel

Once-daily atazanavir/ritonavir versus twice-daily lopinavir/ritonavir, each in combination with tenofovir and emtricitabine, for management of antiretroviral-naive HIV-1-infected patients: 48 week ef...

Export this record

Export record to excel

Identification of I50L as the Signature Atazanavir (ATV)-Resistance Mutation in Treatment-Naive HIV-1-Infected Patients Receiving ATV-Containing Regimens

Export this record

Export record to excel

Body Fat and Other Metabolic Effects of Atazanavir and Efavirenz, Each Administered in Combination with Zidovudine plus Lamivudine, in Antiretroviral- Naive HIV-Infected Patients

Export this record

Export record to excel

Discovery of the Novel Entecavir‐Resistant Hepatitis B Virus Reverse Transcriptase A181C Substitution From an Integrated Genotypic Analysis

Export this record

Export record to excel

Safety of Rimegepant in Patients Using Preventive Migraine Medications: A Subgroup Analysis of a Long-Term, Open-Label Study Conducted in the United States

Export this record

Export record to excel

Efficacy and Safety of Rimegepant 75 mg Oral Tablet, a CGRP Receptor Antagonist, for the Acute Treatment of Migraine: A Randomized, Double-Blind, Placebo-Controlled Trial

Export this record

Export record to excel

Efficacy and Safety of Rimegepant 75 Mg Oral Tablet, a CGRP Receptor Antagonist, for the Acute Treatment of Migraine: A Randomized, Double-Blind, Placebo-Controlled Trial [Corrigendum]

Export this record

Export record to excel

Safety of Rimegepant in Patients Using Preventive Migraine Medications: A Subgroup Analysis of a Long-Term, Open-Label Study Conducted in the United States

Export this record

Export record to excel

Once-daily atazanavir/ritonavir versus twice-daily lopinavir/ritonavir, each in combination with tenofovir and emtricitabine, for management of antiretroviral-naive HIV-1-infected patients : 48 week e...

Export this record

Export record to excel

Body fat and other metabolic effects of atazanavir and efavirenz, each administered in combination with zidovudine plus lamivudine, in antiretroviral- naive HIV-infected patients. Commentary

Export this record

Export record to excel

Atazanavir—A Once-daily HIV Protease Inhibitor That Does Not Cause Dyslipidemia in Newly Treated Patients: Results from Two Randomized Clinical Trials

Export this record

Export record to excel

Missing Data Methods in Hiv Clinical Trials: Regulatory Guidance and Alternative Approaches

Refine your search